Long-term outcomes in patients with ipilimumab-naive advanced melanoma in the phase 3 Keynote-006 study who completed pembrolizumab treatment.
Carlino, M Robert, C Long, G Schachter, J Arance, A Grob, J Mortier, L Daud, A McNeil, C MLotem,
Carlino, M
Robert, C
Long, G
Schachter, J
Arance, A
Grob, J
Mortier, L
Daud, A
McNeil, C
MLotem,
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Long-term outcomes in patients with ipilimumab-naive advanced melanoma in the phase 3 Keynote-006 study who completed pembrolizumab treatment. 2017, 13(50): 50-51 Asia Pac J Clin Oncol